Cost-effectiveness analysis of medical management versus conservative surgery for early tubal pregnancy
Author(s) -
Guillaume Bourel,
Nathalie PelletierFleury,
Jean Bouyer,
A. Delbarre,
H. Fernandez,
P. Capmas
Publication year - 2018
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dey352
Subject(s) - medicine , pregnancy , cost effectiveness analysis , randomized controlled trial , obstetrics , surgery , cost effectiveness , risk analysis (engineering) , genetics , biology
Is conservative surgery (laparoscopic salpingotomy) cost-effective, using fertility as the endpoint compared with medical management (Methotrexate) in women with an early tubal pregnancy?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom